Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies
Parisa Amirifar(Children's Medical Center), Hassan Abolhassani(University of Bonn), Alessandro Plebani(University of Brescia), Reza Yazdani(Children's Medical Center), Anne Durandy(Hôpital Necker-Enfants Malades), Asghar Aghamohammadi(Amirkabir University of Technology), Vassilios Lougaris(University of Brescia), Mohammad Reza Ranjouri(Children's Medical Center), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Lennart Hammarström(Karolinska Institutet)
Cited by 15
Related Papers
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet|2020|19.7k
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet|2020|9.8k